Serial uterine artery Doppler velocity parameters and human uterine receptivity in IVF/ICSI cycles

Size: px
Start display at page:

Download "Serial uterine artery Doppler velocity parameters and human uterine receptivity in IVF/ICSI cycles"

Transcription

1 Ultrasound Obstet Gynecol 2008; 31: Published online 4 February 2008 in Wiley InterScience ( DOI: /uog.5179 Serial uterine artery Doppler velocity parameters and human uterine receptivity in IVF/ICSI cycles D.A.HOOZEMANS,R.SCHATS,N.B.LAMBALK,R.HOMBURGandP.G.A.HOMPES VU University Medical Center Amsterdam, IVF Center, Amsterdam, The Netherlands KEYWORDS: embryo implantation; ICSI; IVF; serial Doppler ultrasound ABSTRACT Objective To evaluate the predictive value of serial uterine artery Doppler ultrasound for embryo implantation in in-vitro fertilization (IVF)-intracytoplasmic sperm injection (ICSI) cycles. Methods This was a prospective observational study at the VU University Medical Center, Amsterdam. Patients with an indication for IVF or IVF-ICSI according to departmental protocol underwent controlled ovarian hyperstimulation followed by IVF or IVF-ICSI and embryo transfer and had serial Doppler ultrasound performed during this treatment cycle. Patient and cycle characteristics, number of conceptions and ongoing pregnancies and pulsatility index (PI) of both uterine arteries on different cycle days were assessed and results were compared between patients who conceived and those who did not. Results Of the 102 patients enrolled into the study, 83 underwent embryo transfer. Of these, 41 became pregnant and 42 did not (Group 1). Of the 41 pregnancies, 30 were ongoing (Group 2) and 11 miscarried (Group 3). Between Groups 1, 2 and 3, linear regression revealed no significant difference between any of the variables examined except in the quality of transferred embryos. There was no significant difference in the mean PI of the left and right uterine arteries on any day of the cycle, or in the change in PI during the cycle. Receiver operating characteristics curves derived to determine the performance of PI to predict pregnancy outcome supported our findings that the uterine artery PI is not a suitable marker for identifying patients with implantation failure. Multivariate analysis showed no relationship between pregnancy and PI between groups, but it did show a relationship between pregnancy and some patient and cycle characteristics. Conclusion In an unselected group of patients undergoing IVF or IVF-ICSI and embryo transfer, serial Doppler ultrasound examination of the uterine artery does not discriminate between cycles resulting in ongoing pregnany, miscarriage and no pregnancy. Copyright 2008 ISUOG. Published by John Wiley & Sons, Ltd. INTRODUCTION The major limiting factor for success in in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles is embryo implantation. Despite developments in laboratory techniques and ovarian stimulation protocols, the implantation rate per embryo transferred remains approximately 15% 1. Embryo implantation depends on two parallel and probably interacting processes: embryonic development, which seems most crucial, resulting in an embryo equipped for implantation; and endometrial development, leading to uterine receptivity. Uterine receptivity depends on many biochemical and structural changes in the endometrium during the course of the menstrual cycle 2. Research on such factors has led to the identification of a window of implantation (5 7 days postovulatory) 3,4 outside which the uterus is refractory even to an otherwise normal embryo that has implantation potential. Identification of the window of implantation and its qualitative assessment in the individual patient has major clinical implications. Suitable assessment of uterine receptivity could be achieved through ultrasound because of its noninvasive nature. Various sonographic parameters, such as endometrial echogenicity, uterine contractility and Doppler parameters, have been evaluated as markers of receptivity 5. Doppler ultrasound seems the most popular technique among clinicians because of its reproducibility. Uterine blood flow can be assessed by Doppler ultrasound in the uterine arteries and there is evidence of an association between abnormal uterine artery blood velocities Correspondence to: Dr D. A. Hoozemans, VU University Medical Center Amsterdam, IVF Center, Poli Zuid, PO BOX 7057, 1007 MB Amsterdam, The Netherlands ( da.hoozemans@vumc.nl) Accepted: 7 June 2007 Copyright 2008 ISUOG. Published by John Wiley & Sons, Ltd. ORIGINAL PAPER

2 Serial uterine artery flow velocities and IVF-ICSI 433 and infertility 5 7 ; the pulsatility index (PI) is considered best at reflecting uterine artery blood velocity parameters. Using uterine artery PI as a marker of implantation has been found successful by some authors while it has been rejected by others Modern Doppler ultrasound techniques, with high-frequency transvaginal probes and color imaging, have far more acceptable intra- and interobserver variation than were possible in the early days of ultrasound 22. The cyclical vascular changes 2 of the endometrium, with angiogenesis and vasodilatation occurring in the implantation window, suggest a time relationship with embryo implantation. Further support for this relationship derives from the observation that known histological and biochemical 12 markers of receptivity correlate with Doppler findings 23. The window of implantation is characterized by a state of increased vascular permeability, massive endometrial angiogenesis 24 and decreased vascular resistance 2. Uterine perfusion is modulated by ovarian hormones; estrogens reduce the vascular impedance both in spontaneous cycles 6,8 and in estrogen and progesterone replacement cycles 9,10. Progesterone increases this effect towards the mid-luteal phase (i.e. the window of implantation), when vascular resistance is minimal and uterine perfusion is maximal 6,11,25. Various other vascular factors, such as prostaglandins and vascular endothelial growth factor, are involved in this monthly vascular endometrial development and their absence leads to subfertility 2. The ultimate proof of this concept of the relationship between vascular changes and successful implantation is the establishment of pregnancy in relation to uterine perfusion. Many authors have addressed the subject of uterine perfusion and its correlation to receptivity. Some found a positive correlation 13 18, while others did not 19,20. However, no previous publication has used serial measurements to assess true physiological changes during a treatment cycle. This seems imperative because the range of PI values between patients, which could lead to overlapping normal and abnormal values, is well known. Previous studies have found that cut-off PI-values for implantation failure range from to ,18.Also, the day of assessment does not seem to be of major importance for the predictive value 23. Therefore, in order to study receptivity sonographically, the patient herself should be used as a reference. In this study we focused on changes in PI in the individual patient during IVF to determine whether serial PI assessments in an IVF or IVF-ICSI cycle reflect a process of endometrial vascular development that predicts the possibility of successful implantation. We hypothesized that a decrease in PI would be observed during the IVF or IVF-ICSI cycle and that this phenomenon would be more pronounced in cycles resulting in pregnancy. To identify confounding factors, such as embryo quality, number of embryos transferred, maternal age, indication for IVF and the stimulation protocol, which might affect the chance of pregnancy directly or indirectly by influencing PI, we used multivariate analysis. METHODS Inclusion and treatment Between March 2002 and December 2003, a total of 102 patients who had an indication for IVF or IVF-ICSI treatment according to the criteria of the division of reproductive medicine of the VU University Medical Center consented to participate in this study. Indications included: idiopathic infertility, either IVF or IVF-ICSI male factor sub fertility (sperm count > 1 million for IVF and < 1 million for IVF-ICSI), and external endometriosis Grade I or II. Inclusion criteria were: age < 39 years, regular menstrual cycle with two normal, nonpolycystic ovaries present at the time of enrollment, and a follicle stimulating hormone (FSH) level < 10 IU/L on cycle day 3. Patients with tubal factor infertility (after pelvic inflammatory disease or with hydrosalpinges), a history of uterine surgery and/or apparent endometrial pathology (polyps, submucous myoma or synechia) were excluded, as were patients with clinically relevant systemic diseases, such as diabetes mellitus, ulcerative colitis, Crohn s disease, connective tissue diseases or hypertension. Smoking and a body mass index > 28 kg/m 2 were also exclusion criteria. Each patient was included only once. Patients were stimulated according to our standard long agonist protocol, starting with 30 µg ethinylestradiol and 150 µg levonorgestrel (Microgynon 30, Schering, Mijdrecht, The Netherlands) administered orally on cycle day 3 and continued until cycle day 24. From cycle day 17 we started treatment with 0.1 mg triptorelin-acetate (Decapeptyl, Ferring, Hoofddorp, The Netherlands) daily until the day of ovum pick-up. After withdrawal bleeding started, controlled ovarian hyperstimulation was commenced from cycle day 3 with recombinant FSH (follitrophin beta, Puregon, Organon, OSS, The Netherlands) in an individually adjusted dose that depended on age and antral follicle count. Patients were monitored with regular transvaginal ultrasound examinations and urinary hcg IU/ampoule (Profasi, Serono, Denhaag, The Netherlands) was administered to induce final follicular maturation according to protocol 26. Transvaginal ultrasound-guided follicular aspiration was performed 36 h after hcg administration and the number of oocytes was assessed under a microscope. Fertilization was achieved by either IVF or ICSI and the number and of embryos was noted. Embryo quality was assessed by experienced IVF laboratory technicians using a score based on the number of blastomeres; an overall score of 1 4 was given based on the scoring system described by Roseboom et al. 26 and Steer et al. 27. At 2 3 days after ovum pick-up, a maximum of two embryos was placed into the uterine cavity. The luteal phase was supported by 100 mg Progestan (Organon) three times daily until a pregnancy test was done days after ovum pick-up. Pregnancy was the primary endpoint. Clinical pregnancy was defined by serum hcg > 50 IU/L on day post follicle aspiration, increased hcg levels 1 week after initial assessment and the appearance of a gestational

3 434 Hoozemans et al. sac on ultrasound. Ongoing pregnancy was defined by positive fetal cardiac activity at 12 weeks gestation. Ultrasound Transvaginal sonographic measurements were performed by two observers (R.S. and D.A.H.). Uterine artery Doppler flow velocity measurements were carried out with the patient in a standard lithotomy position, using an Aloka SSD 4000 Prosound Pure HD ultrasound machine (Aloka, Tokyo, Japan) equipped with a 7.5- MHz transvaginal probe. The observations were made on specific cycle days as indicated in Table 1 and were carried out on mornings to avoid fluctuations due to the normal circadian rhythm of uterine blood flow. We assessed the PI after validation of the inter- and intraobserver variation (intraclass correlation coefficient (ICC), 0.92 (95% CI, ) for intraobserver variation and ICC, 0.95 (95%CI, ) for interobserver variation). The mean PI of left and right uterine arteries was used for analysis. Statistical analysis Univariate analysis was performed on the PI on the different assessment days, comparing absolute PI values in relation to pregnancy outcome. Univariate analysis was also used to relate the changes in PI values in the different outcome groups. Multivariate analysis (logistic regression model) was used to investigate the influence of possible confounders on the chances of pregnancy, using PI, maternal age, endometrial thickness on day of hcg injection, treatment (IVF/ICSI), IVF indication, primary or secondary infertility and total embryo quality as explanatory variables and pregnancy as the primary outcome variable. The power calculation indicated a sample size of 100 (alpha 5, estimated averages, 2.00 for pregnant and 3.00 for non-pregnant and estimated 75% non-pregnant and 25% pregnant). The test characteristics of uterine artery PI on different cycle days for embryo implantation were expressed by receiver operating characteristics (ROC) curves and the areas under the curves (AUC). The study was conducted according to the declaration of Helsinki revised in 1983 and in accordance with the research guidelines of our institute. The study was approved by the institute s review board and patients gave their written informed consent. RESULTS One hundred and two patients were enrolled into the study. Seventeen patient cycles were cancelled because of low response, prevention of ovarian hyperstimulation syndrome or fertilization failure. One patient withdrew her informed consent before starting ovarian hyperstimulation. One patient had to be excluded from the study due to violation of the protocol (it was later discovered that she smoked). Thus, 83 patients underwent embryo transfer of at least one embryo. Of these, 42 patients had a negative pregnancy test 15 days after ovum pick-up (Group 1), and 41 patients conceived. In the 41 pregnant patients there were 30 ongoing pregnancies, determined by ultrasound at 12 weeks gestation (Group 2), and 11 miscarriages/biochemical pregnancies (Group 3). The miscarriages, of which there were four, occurred at 7, 7, 8 and 9 weeks. Because of their low number they were not evaluated separately. It is possible, however, that these had a different etiology from the biochemical pregnancy losses, miscarriages being caused probably by embryonic factors (chromosomal abnormalities) and biochemical pregnancy losses having a more endometrial-driven etiology. Table 2 shows the patient characteristics of the participants and their treatment cycle characteristics. There were no significant differences between pregnant and non-pregnant patients with respect to age, cause of infertility, primary or secondary infertility or number of previous IVF attempts. The multivariate model revealed a correlation between pregnancy and: age (inverse correlation) and number and quality of embryos (positive correlation) and subfertility factor (data not shown). The individual treatment cycle characteristics did not yield discriminating factors for successful implantation. The only significant factor found was the embryo quality as assessed by light microscopy. In all patient groups there was a decrease in PI towards the mid-luteal phase, indicating a decrease in resistance of the uterine circulation, which would possibly allow better perfusion of the uterus (Table 3). However, there was an increase in PI at 15 days after ovum pick-up in Table 1 Timing of pulsatility index measurements during in-vitro fertilization/intracytoplasmic sperm injection treatment cycle, with corresponding physiological stages Phase of treatment cycle Cycle day (mean (range)) Event Start down-regulation cycle 3 (1 4) Start (basal value) Day of hcg administration 12 (10 14) Maximum E2 levels, pre-lh surge Day of ovum pick-up 14 (12 16) Ovulation, start luteal phase Day of embryo transfer 17 (14 19) Embryo enters uterus and process of hatching is initiated Ovulation day (20 25) Onset of nidation and trophoblast invasion Day of pregnancy test 29 (27 33) Implantation complete E2, estradiol; hcg, human chorionic gonadotropin; LH, luteinizing hormone.

4 Serial uterine artery flow velocities and IVF-ICSI 435 Table 2 Patient and in-vitro fertilization (IVF)-intracytoplasmic sperm injection (ICSI) treatment cycle characteristics according to study group Group Variable 1: not pregnant (n = 42) 2: ongoing pregnancy (n = 30) 3: biochemical pregnancy (n = 7)/ miscarriage (n = 4) Age (years) 33.5 ± ± ± 4.0 Idiopathic factor 13 (31) 8 (27) 3 (27) Male factor IVF 16 (38) 12 (40) 1 (9) Male factor ICSI 12 (29) 8 (27) 5 (45) Endometriosis Grade I or II 1 (2) 2 (7) 2 (18) Primary infertility 32 (76) 20 (67) 8 (73) Secondary infertility 10 (24) 10 (33) 3 (27) Number of previous cycles 4 ± ± ± 1.64 Total FSH dose received (IU) 2428 ± ± ± 643 Number of stimulation days 12.2 ± ± ± 1.35 Number of oocytes retrieved ± ± ± 6.87 Number of embryos formed 7.45 ± ± ± 5.11 Score of transfer embryos 4.36 ± 1.14* 5.1 ± 1* 4.3 ± 1.62* Timing of embryo transfer: 2 days after ovum pick-up 7 (17) 3 (10) 1 (9) 3 days after ovum pick-up 35 (83) 27 (90) 10 (91) Endometrial thickness (mm) 9.95 ± ± ± 6 Values are mean ± SD or n (%). ANOVA or Chi-square tests were used as applicable. *P < 5. FSH, follicle stimulating hormone. Table 3 Mean (SD) pulsatility index (PI) values in different study groups undergoing in-vitro fertilization/intracytoplasmic sperm injection Group Timing of PI measurement 1: not pregnant (n = 42) 2: ongoing pregnancy (n = 30) 3: biochemical pregnancy/ miscarriage (n = 11) P Start down-regulation cycle 2.18 (7) 2.32 (0.50) 2.18 (8) 0.51 Day of hcg administration 2.11 (7) 2.19 (0.56) 2.15 (0.38) 0.78 Day of ovum pick-up 2.08 (0.38) 2.13 (0.38) 2.15 (1) 2 Day of embryo transfer 1.84 (0) 2.04 (0.59) 1.98 (0.37) 0 Ovulation day (3) 1.75 (1) 1.73 (0.36) 0.94 Day of pregnancy test 1.89 (7) 1.85 (0) 1.87 (0.50) 0.94 hcg, human chorionic gonadotropin. pregnant as well as in non-pregnant patients. There was no significant difference between the groups in the change (decrease) in PI from the start of the cycle towards the day of embryo transfer and beyond (Table 4). Table 5 presents the results of the multivariate logistic regression analysis. Odds ratios for PI were not significant, indicating that the amount of decrease in PI did not discriminate between cycles that resulted in pregnancy and cycles that did not. This was regardless of the other variables in the model. ROC curves on different cycle days indicated the poor test characteristics (sensitivity and specificity) of PI as an implantation marker (Figure 1), with areas under the curve of between 1 and DISCUSSION The success of human embryo implantation depends on maternal and embryonic factors and their interactions. To assess uterine receptivity one must take various factors into account. The main factor determining success, identified by various studies (reviewed by Hoozemans et al. 2 ), is probably embryo quality as determined by light microscopy. Our results confirmed this. We tried to increase the sensitivity of PI for implantation by performing serial measurements in the same patient, to assess true physiological changes involved in the endometrial vascular development cycle. Because vascular development is imperative for a receptive endometrium, its assessment by Doppler ultrasound might be predictive for implantation. We must now reject this hypothesis because there were no significant differences in PI on any of the cycle days and in the change in PI through the treatment cycle. We observed a wide range of PI values that were distributed almost equally between pregnant patients, non-pregnant patients and patients with a failed pregnancy (Tables 3 and 4). It is remarkable that in our

5 436 Hoozemans et al. Table 4 Mean (SD) changes in pulsatility index (PI) values between cycle days in different study groups undergoing in-vitro fertilization/intracytoplasmic sperm injection Group Period over which PI changed 1: not pregnant (n = 42) 2: ongoing pregnancy (n = 30) 3: biochemical pregnancy/ miscarriage (n = 11) P Baseline: start of down-regulation cycle 2.18 (7) 2.32 (0.50) 2.18 (8) 0.51 To day of hcg administration 8 (0.52) 0.14 (9) 4 (0.57) 4 To day of ovum pick-up 0.11 (7) 0 (7) 4 (0.57) 8 To day of embryo transfer 0.35 (0.51) 0.30 (0.78) 0.31 (0.70) 2 To ovulation day (0.53) 0.55 (0.56) 6 (7) 0.79 To day of pregnancy test 0.30 (0.59) 7 (3) 0.32 (0.96) 0.55 Values were considered significant if P < 5. (a) (b) (c) (d) (e) (f) Figure 1 Receiver operating characteristics curves for uterine artery pulsatility index measurements during in-vitro fertilization-intracytoplasmic sperm injection treatment cycles, with assessment: (a) on day of start of the cycle (area under the curve (AUC) = 1), (b) at end of stimulation phase (AUC = 3), (c) at ovum pick-up (AUC = 4), (d) at embryo transfer (AUC = 1), (e) at mid-luteal phase (AUC = 6) and (f) on day of pregnancy test, days after ovum pick-up (AUC = 0.53). univariate analysis the only significant difference in patient characteristics or cycle characteristics between pregnant patients and non-pregnant patients was embryo score of the transferred embryos. It is well known that female age, for example, is a strong determining factor in IVF success rates, but we could not substantiate this, probably due to the small size of our study group. The small size of our study group might also be responsible for the absence of significant differences in uterine vascular impedance values. Another possible explanation is that, although vascular endometrial development is crucial for implantation, it is not so crucial in the stage that we assessed. This might be because during the window of implantation the embryo is

6 Serial uterine artery flow velocities and IVF-ICSI 437 Table 5 Results of logistic regression analysis Variable Odds ratio 95% CI Change in PI to: Day of hcg administration Day of ovum pick-up Day of embryo transfer Ovulation day Day of pregnancy test Odds ratio was considered significant if a value of 1 did not fall within the 95% CI. In the model, pregnancy was the outcome and pulsatility index (PI), age, endometrial thickness on day of human chorionic gonadotropin (hcg) injection, treatment (in-vitro fertilization (IVF)-intracytoplasmic sperm injection (ICSI)), IVF indication, primary or secondary infertility and total embryo quality were explanatory variables. a known anaerobic organism which is best cultured invitro in a low-oxygen atmosphere 28. Whether/when this state changes in the intrauterine phase of treatment is not known. In fact, we did see in follow-up studies of these patients that PIs remained low (or even tended to decrease a little further) in the first trimester of pregnancy (data not shown). Around the time of hatching and attachment of the embryo, the local circumstances in the uterus are optimal, but it seems that to a great extent factors involving the embryo itself determine whether implantation will take place. In fact, the uterus is perhaps more limiting than it is facilitating to implantation. It is well known that endometrium is not essential for embryo implantation, as proved by the occurrence of ectopic pregnancies 29.The uterus is actually the only female organ that protects the mother actively from the invasive growth and potentially destructive trophoblast. One final possible explanation of our findings, with the uterine artery being some distance from the site of implantation and not supplying the endometrium exclusively, is that the assessment of uterine artery PI was not sufficiently sensitive to assess the microvascular events of embryo implantation. In conclusion, we have shown that there does not seem to be a place for PI assessment as a routine non-invasive marker of implantation. Future research should always compensate for known confounders and assess whether there is a role for PI in a more selected population, looking in more detail in and around the window of implantation. Investigation of the vascular process of embryo implantation by assessing known markers of angiogenesis and vascular growth factors combined with ultrasound will hopefully lead to greater understanding of this process. REFERENCES 1. Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2000; 74: Hoozemans DA, Schats R, Lambalk CB, Homburg R, Hompes PG. Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reprod Biomed Online 2004; 9: Psychoyos A. Hormonal control of ovoimplantation. Vitam Horm 1973; 31: Psychoyos A. Hormonal control of uterine receptivity for nidation. J Reprod Fertil Suppl 1976; 25: Fanchin R. Assessing uterine receptivity in 2001: ultrasonographic glances at the new millennium. Ann N Y Acad Sci 2001; 943: Steer CV, Campbell S, Pampiglione JS, Kingsland CR, Mason BA, Collins WP. Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum Reprod 1990; 5: Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion a cause of infertility. Hum Reprod 1988; 3: Goswamy RK, Steptoe PC. Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Hum Reprod 1988; 3: de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991; 55: Achiron R, Levran D, Sivan E, Lipitz S, Dor J, Mashiach S. Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study. Fertil Steril 1995; 63: Scholtes MC, Wladimiroff JW, van Rijen HJ, Hop WC. Uterine and ovarian flow velocity waveforms in the normal menstrual cycle: a transvaginal Doppler study. Fertil Steril 1989; 52: Steer CV, Tan SL, Dillon D, Mason BA, Campbell S. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil Steril 1995; 63: Sterzik K, Grab D, Sasse V, Hutter W, Rosenbusch B, Terinde R. Doppler sonographic findings and their correlation with implantation in an in vitro fertilization program. Fertil Steril 1989; 52: Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA, Collins WP. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992; 57: Coulam CB, Bustillo M, Soenksen DM, Britten S. Ultrasonographic predictors of implantation after assisted reproduction. Fertil Steril 1994; 62: Serafini P, Batzofin J, Nelson J, Olive D. Sonographic uterine predictors of pregnancy in women undergoing ovulation induction for assisted reproductive treatments. Fertil Steril 1994; 62: Zaidi J, Pittrof R, Shaker A, Kyei-Mensah A, Campbell S, Tan SL. Assessment of uterine artery blood flow on the day of human chorionic gonadotropin administration by transvaginal color Doppler ultrasound in an in vitro fertilization program. Fertil Steril 1996; 65: Cacciatore B, Simberg N, Fusaro P, Tiitinen A. Transvaginal Doppler study of uterine artery blood flow in in vitro fertilization-embryo transfer cycles. Fertil Steril 1996; 66: Tekay A, Martikainen H, Jouppila P. Blood flow changes in uterine and ovarian vasculature, and predictive value of transvaginal pulsed colour Doppler ultrasonography in an invitro fertilization programme. Hum Reprod 1995; 10: Yang JH, Wu MY, Chen CD, Jiang MC, Ho HN, Yang YS. Association of endometrial blood flow as determined by a modified colour Doppler technique with subsequent outcome of in-vitro fertilization. Hum Reprod 1999; 14: Chien LW, Tzeng CR, Chang SR, Chen AC. The correlation of the embryo implantation rate with uterine arterial impedance

7 438 Hoozemans et al. in in vitro fertilization and embryo transfer. Early Pregnancy 1995; 1: Steer CV, Williams J, Zaidi J, Campbell S, Tan SL. Intraobserver, interobserver, interultrasound transducer and intercycle variation in colour Doppler assessment of uterine artery impedance. Hum Reprod 1995; 10: Schild RL, Holthaus S, d Alquen J, Fimmers R, Dorn C, van Der Ven H, Hansmann M. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod 2000; 15: Smith SK. Angiogenesis and implantation. Hum Reprod 2000; 15 (Suppl 6): Tan SL, Zaidi J, Campbell S, Doyle P, Collins W. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle. Am J Obstet Gynecol 1996; 175: Roseboom TJ, Vermeiden JP, Schoute E, Lens JW, Schats R. The probability of pregnancy after embryo transfer is affected by the age of the patient, cause of infertility, number of embryos transferred and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod 1995; 10: Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an invitro fertilization and embryo transfer programme. Hum Reprod 1992; 7: Bavister B. Oxygen concentration and preimplantation development. Reprod Biomed Online 2004; 9: Lenglet JE, Bekker MN, Akkerman C, Bolte AC, van Vugt JM. Prenatal ultrasound and MRI predict placental localization in a combined intrauterine and extrauterine twin pregnancy. Prenat Diagn 2006; 26:

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study . M.,nopause FERTILITY AND STERILITY Vol. 63, No.3, March 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. Endometrial blood flow response to hormone

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

Article Role of utero ovarian vascular impedance: predictor of ongoing pregnancy in an IVF embryo transfer programme

Article Role of utero ovarian vascular impedance: predictor of ongoing pregnancy in an IVF embryo transfer programme RBMOnline - Vol 9. No 3. 2004 299-305 Reproductive BioMedicine Online; www.rbmonline.com/article/1383 on web 12 July 2004 Article Role of utero ovarian vascular impedance: predictor of ongoing pregnancy

More information

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie

More information

Utility of color Doppler indices of dominant follicular

Utility of color Doppler indices of dominant follicular Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo

More information

ASSESSMENT OF ENDOMETRIAL-SUBENDOMETRIAL BLOOD FLOW DETECTED BY COLOR DOPPLER SONOGRAPHY AND UTERINE RECEPTIVITY IN INFERTILE WOMEN

ASSESSMENT OF ENDOMETRIAL-SUBENDOMETRIAL BLOOD FLOW DETECTED BY COLOR DOPPLER SONOGRAPHY AND UTERINE RECEPTIVITY IN INFERTILE WOMEN ORIGINAL REPORT ASSESSMENT OF ENDOMETRIAL-SUBENDOMETRIAL BLOOD FLOW DETECTED BY COLOR DOPPLER SONOGRAPHY AND UTERINE RECEPTIVITY IN INFERTILE WOMEN M. Aghahoseini *, K. Tuba, V. Marsousi and A. Aleyasin

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study

Medicine. Wei Yang, MMed, Tao Zhang, MMed, Zhou Li, PhD, Xinling Ren, PhD, Bo Huang, PhD, Guijin Zhu, MMed, Lei Jin, PhD. Observational Study Observational Study Medicine Combined analysis of endometrial thickness and pattern in predicting clinical outcomes of frozen embryo transfer cycles with morphological good-quality blastocyst A retrospective

More information

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization Original Article Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hcg by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a

More information

Power Doppler Endometrial Evaluation as a Method for the Prognosis of Embryo Implantation in an ICSI Program

Power Doppler Endometrial Evaluation as a Method for the Prognosis of Embryo Implantation in an ICSI Program CLINICAL ASSISTED REPRODUCTION Power Doppler Endometrial Evaluation as a Method for the Prognosis of Embryo Implantation in an ICSI Program PAULA CONTART, 1 RICARDO LUIZ RAZERA BARUFFI, 1 JOAQUIM COELHO,

More information

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency

More information

Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer

Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer Xingqi Zhang, Ph.D., a Chi-Huang Chen, M.D., b Edmond

More information

Research Article. Manisha Choudhary 1 *, Jai Chowdhary 2, Mohan Lal Swarankar 1, Shiv Lal Bharadwaj 3

Research Article. Manisha Choudhary 1 *, Jai Chowdhary 2, Mohan Lal Swarankar 1, Shiv Lal Bharadwaj 3 International Journal of Research in Medical Sciences Choudhary M et al. Int J Res Med Sci. 2015 Nov;3(11):3114-3118 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151146

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko

More information

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium.

Objective: To study the role of sildenafil on the echogenic pattern of endometrium in infertile patients with bad endometrium. The effect of Sildenafil on endometrial characters in patients with infertility Ali F. Al-Assadi, F.I.C.O.G.,C.A.B.O.G.1. Sajeda A. Al-Rubaye, F.I.C.O.G.1 Zainab Laaiby, M.B.Ch.B.2 (1- Assist. Prof./Basra

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D., FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,

More information

Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation

Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Original Article Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Aaida Mumtaz, MBBS. 1#, Aqsa Khalid, MBBS. 1#, Zehra Jamil, M.Phil. 2, Syeda Sadia Fatima, Ph.D.

More information

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic

More information

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should

More information

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile

More information

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization

The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization Human Reproduction vol.12 no.6 pp.1240 1245, 1997 The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization S.Bassil 1, C.Wyns, D.Toussaint-Demylle, M.Nisolle,

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150

More information

Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles

Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles ORIGINAL ARTICLE Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles Farnaz Sohrabvand 1, Mamak Shariat 2, Navid Fotoohi Ghiam 3, and Mahdi Hashemi

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles? J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation

More information

Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support

Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support FERTILITY AND STERILITY Vol. 64, No.1, July 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Modifications in uterine and intraovarian artery impedance

More information

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing

More information

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

Correspondence: Tel: ; Fax: ;

Correspondence:   Tel: ; Fax: ; RBMOnline - Vol 16. No 3. 2008 368-375 Reproductive BioMedicine Online; www.rbmonline.com/article/3055 on web 21 January 2008 Article Optimal timing of ultrasonographic and Doppler evaluation of uterine

More information

Prognosticating ovarian reserve by the new ovarian response prediction index

Prognosticating ovarian reserve by the new ovarian response prediction index International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917

More information

Jinan Bekir, M.D. Amma Kyei-Mensah, M.D. Seang-Lin Tan, M.D.

Jinan Bekir, M.D. Amma Kyei-Mensah, M.D. Seang-Lin Tan, M.D. FERTILITY AND STERILITY Copyright ~ 1995 American Society for Reproductive Mediciue Vol. 64, No.4, October 1995 Printed on acid-free paper in U. S. A. Administration of progestogens to hasten pituitary

More information

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27

More information

N.A.Bersinger 1, A.Brandenberger, E.Berger, C.K.Baumann and M.H.Birkhäuser

N.A.Bersinger 1, A.Brandenberger, E.Berger, C.K.Baumann and M.H.Birkhäuser Human Reproduction vol.13 no.7 pp.1962 1967, 1998 Serum pregnancy-specific β 1 -glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro

More information

Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ ICSI: a randomized, placebocontrolled,

Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ ICSI: a randomized, placebocontrolled, Human Reproduction, Vol.24, No.4 pp. 861 866, 2009 Advanced Access publication on January 18, 2009 doi:10.1093/humrep/den489 ORIGINAL ARTICLE Infertility Low-dose aspirin and uterine haemodynamics on the

More information

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization IVF 1878 - first reported attempts at IVF 1959 - IVF births in rabbits in USA 1968

More information

IVF Protocols: Hyper & Hypo-Responders, Implantation

IVF Protocols: Hyper & Hypo-Responders, Implantation IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient

More information

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Three-dimensional

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

DSJUOG ABSTRACT INTRODUCTION /jp-journals

DSJUOG ABSTRACT INTRODUCTION /jp-journals Firoozeh Ahmadi et al ORIGINAL ARTICLE 10.5005/jp-journals-10009-1491 A Two-year Cross-sectional Prospective Study for Assessment of Endometrial Thickness and Volume using Three-dimensional Transvaginal

More information

10.7 The Reproductive Hormones

10.7 The Reproductive Hormones 10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid

More information

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring

More information

The effect of endometrial thickness on IVF/ICSI outcome

The effect of endometrial thickness on IVF/ICSI outcome Human Reproduction Vol.18, No.11 pp. 2337±2341, 2003 DOI: 10.1093/humrep/deg461 The effect of endometrial thickness on IVF/ICSI outcome P.Kovacs 1,3, Sz.Matyas 1, K.Boda 2 and S.G.Kaali 1 1 Kaali Institute

More information

Article Prediction of pituitary down-regulation by evaluation of endometrial thickness in an IVF programme

Article Prediction of pituitary down-regulation by evaluation of endometrial thickness in an IVF programme RBMOnline - Vol 8. No 5. 2004 595-599 Reproductive BioMedicine Online; www.rbmonline.com/article/1065 on web 17 March 2004 Article Prediction of pituitary down-regulation by evaluation of endometrial thickness

More information

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D. FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating

More information

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome.

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome. Embryo quality is more important for younger women whereas age is more important for older women with regard to in vitro fertilization outcome and multiple pregnancy Tsung-Hsien Lee, M.D., M.Sc., a,b,c

More information

CHR CENTER FOR HUMAN REPRODUCTION Informed Consent for the Performance of In Vitro Fertilization (IVF) and Related Procedures

CHR CENTER FOR HUMAN REPRODUCTION Informed Consent for the Performance of In Vitro Fertilization (IVF) and Related Procedures Patient Name:. Social Security #: Partner Name: Social Security #: CHR CENTER FOR HUMAN REPRODUCTION Informed Consent for the Performance of In Vitro Fertilization (IVF) and Related Procedures We have

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Changes in measured endometrial thickness predict in vitro fertilization success

Changes in measured endometrial thickness predict in vitro fertilization success Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive

More information

Assisted reproductive technology

Assisted reproductive technology Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo

More information

Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche. Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare

Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche. Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare Carlo Alviggi The rational of Follicular synchronization

More information

Pediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain

Pediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study María-José Escribá, Ph.D.,

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/24779

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

Evaluation of the Infertile Couple

Evaluation of the Infertile Couple Overview and Definition Infertility is defined as the inability of a couple to fall pregnant after one year of unprotected intercourse. Infertility is a very common condition as in any given year about

More information

Effect of GnRH antagonist on follicular development and uterine biophysical profile in controlled ovarian stimulation

Effect of GnRH antagonist on follicular development and uterine biophysical profile in controlled ovarian stimulation International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tiwary B et al. Int J Reprod Contracept Obstet Gynecol. 2015 Feb;4(1):157-163 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization

More information

Fertility assessment and assisted conception

Fertility assessment and assisted conception Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.

More information

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G

More information

Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction

Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction Human Reproduction Page 1 of 5 Hum. Reprod. Advance Access published December 17, 2004 doi:10.1093/humrep/deh677 Follicular diameters in conception cycles with and without multiple pregnancy after stimulated

More information

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nadkarni PK et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):617-621 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s CLINICAL ASSISTED REPRODUCTION Outcome of IVF in DES-Exposed Daughters: Experience in the 90s LUBNA PAL,1,4 JAN L. SHIFREN,1 KEITH B. ISAACSON,1 YUCHIAO CHANG,2 MARTHA MAREAN,3 LUCY LEYKIN,1 and THOMAS

More information

Factors Affecting Intra-Cytoplasm Sperm Injection (ICSI) and Pregnancy Outcome in the Fertility Center of Al Najaf City

Factors Affecting Intra-Cytoplasm Sperm Injection (ICSI) and Pregnancy Outcome in the Fertility Center of Al Najaf City INTRA-CYTOPLASM THE IRAQI POSTGRADUATE SPERM MEDICAL INJECTION JOURNAL Factors Affecting Intra-Cytoplasm Sperm Injection (ICSI) and Pregnancy Outcome in the Fertility Center of Al Najaf City Basima Shamkhi

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

Ari Kim, M.D., Ji Eun Han, M.D., Tae Ki Yoon, M.D., Sang Woo Lyu, M.D., Hyun Ha Seok, M.D., and Hyung Jae Won, M.D.

Ari Kim, M.D., Ji Eun Han, M.D., Tae Ki Yoon, M.D., Sang Woo Lyu, M.D., Hyun Ha Seok, M.D., and Hyung Jae Won, M.D. Relationship between endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound and pregnancy after intrauterine insemination Ari Kim, M.D., Ji Eun Han, M.D., Tae

More information

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/22797

More information

Liyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction

Liyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction doi:10.1111/jog.13305 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1037 1042, June 2017 Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of

More information

Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate

Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate J Obstet Gynecol India Vol. 57, No. 3 : May/June 2007 Pg 234-239 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Comparison of NuvaRing and Desogen in IVF cycles with ganirelix acetate

More information

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D. Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006

More information

Managing infertility when adenomyosis and endometriosis co-exist

Managing infertility when adenomyosis and endometriosis co-exist Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China Endometriosis Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects

More information

Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth

Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Human Reproduction vol.5 no.6 pp.670-674, 1990 Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Yael Gonen 1 and Robert F.Casper Division of Reproductive

More information

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle

5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION

More information

Which is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor

Which is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor Journal of Reproduction & Contraception doi: 10.7669j.issn.1001-7844.2014.01.0041 2014 Mar.; 25(1):41-48 E-mail: randc_journal@163.com Which is the Best Protocol of Ovarian Stimulation Prior to Artificial

More information

In Vitro Fertilization and Embryo Transfer

In Vitro Fertilization and Embryo Transfer Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

Outlook Ultrasound and the receptivity of the endometrium

Outlook Ultrasound and the receptivity of the endometrium RBMOnline - Vol 15 No 1. 2007 63-67 Reproductive BioMedicine Online; www.rbmonline.com/article/2859 on web 16 May 2007 Outlook Ultrasound and the receptivity of the endometrium Stephen Killick has worked

More information

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol

More information

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,

More information